|
|
|
|
Orthobiologic polymer resists biofilm formation |
|
|
| Polymers and elastomers
: 31 May, 2013 |
|
DiFusion completes a series of in vitro tests and an in vivo study, carried out in part at Clemson University, to validate the efficacy of the company's new orthobiologic polymer - CleanFuze.
|
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
PEEK-based spinal implant receives FDA 510(k) approval |
|
|
| Polymers and elastomers
: 16 May, 2013 |
|
Xiphos ALIF, a VESTAKEEP PEEK-based (polyetheretherketone) spinal implant developed by DiFusion Technologies, receives the US Food and Drug Administration's (FDA) 510(k) approval for use in Interbody Fusion Devices (IBF) devices. |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Endomagnetics is pinpointed as a future star business |
|
|
| Medical isotopes
: 19 November, 2012 |
|
The Real Business Future 50 project selects Endomagnetics, the company developing a portfolio of products to improve the standard of breast cancer management, as one of the UK's most exciting, high-potential new businesses. |
| |
|
|
|
 |
|
|
|
|
|
Intertronics releases new medical device adhesive guides |
|
|
| Adhesives
: 29 October, 2012 |
|
The specialist adhesives team at Intertronics is offering a wide portfolio of products specifically designed for medical device assembly with two specific applications focusing on needle bonding and catheter assembly now being addressed in new selector guides from sales partner DYMAX. |
| |
|
|
|
 |
|
|
|
|
|
|
|
Dyax agrees Kadmon strategic licensing agreement for DX-2400 |
|
|
| Biomaterials and biopharmaceuticals
: 21 September, 2012 |
|
Dyax is entering into a strategic licensing agreement with Kadmon which will see Kadmon being granted an exclusive worldwide license for the development and commercialization of the fully human monoclonal antibody DX-2400, a potent and selective antibody inhibitor of matrix metalloproteinase 14 (MMP-14). |
| |
|
|
|
 |
|
|
|
SafeStitch Medical agrees with Herniamesh to distribute mesh |
|
|
| Biomaterials and biopharmaceuticals
: 01 August, 2012 |
|
SafeStitch Medical is entering in a distribution agreement with Herniamesh, an Italian mesh manufacturer operating in the biomedical market, to distribute mesh used for inguinal and ventral hernia repair in the USA. |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bluestar Silicones unveils innovative silicone foams |
|
|
| Polymers and elastomers
: 22 November, 2011 |
|
Bluestar Silicones is launching a new technology, SILBIONE RT Foams, which are liquid materials enabling the production of silicones foams, with low density (from 0.18 to 0.25) and open cells. |
| |
|
|
|
 |
|
|
|
Quintiles acquires VCG and Associates plus VCG Bio |
|
|
| Biomaterials and biopharmaceuticals
: 21 October, 2011 |
|
Quintiles completes the acquisition of VCG and Associates and VCG BIO, based in Holliston, Massachusetts, and Cave Creek, Arizona, respectively. |
| |
|
|
|
 |
|
|
|
MD Anderson Cancer Center orders Cesium-131 for cancer study |
|
|
| Medical isotopes
: 11 October, 2011 |
|
MD Anderson Cancer Center initiates orders of Cesium-131 brachytherapy (internal radiation therapy) seeds from IsoRay as it continues the centre's clinical research study investigating brachytherapy's ability to help control intermediate risk prostate cancer. |
| |
|
|
|
 |
|
|
|
Bio-compatible 3D printing material provides medical solutions |
|
|
| Biomaterials and biopharmaceuticals
: 23 September, 2011 |
|
Objet launches a new bio-compatible 3D printing material (MED610) that combines bio-compatibility with high dimensional stability and clear transparency making it useful for PMMA simulation and a wide range of medical and dental applications - particularly the production of highly accurate, customised surgical guides. |
| |
|
|
|
 |
|
|
|
|
|
CamStent raises seed funding to develop antimicrobial coating |
|
|
| Coatings and finishes
: 09 September, 2011 |
|
Results from a study demonstrates that CamStent's first product from its surface coating platform exerts strong antimicrobial effects against the organisms primarily responsible for hospital-acquired urinary-tract infections. |
| |
|
|
|
 |
|
|
|
|
|
GE Healthcare plans acquisition of PAA Laboratories |
|
|
| Biomaterials and biopharmaceuticals
: 18 August, 2011 |
|
GE Healthcare agrees to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry. |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
NuSil unveils two new thermally conductive healthcare silicone elastomers |
|
|
| Polymers and elastomers
: 06 April, 2011 |
|
NuSil Technology is introducing two thermally conductive healthcare silicone elastomers which can be used as a cure-in-place adhesive or potting compound between electrical and electronic components and heat sinks as part of a thermal management regime to keep medical devices operating at optimal levels. |
| |
|
|
|
 |
|
|
|
|
|
Vexim receives US FDA certification for new bone cement solution |
|
|
| Bone substitute materials
: 01 April, 2011 |
|
Vexim receives US FDA certification for its flagship product Cohesion, a bone cement for injection into the vertebra for its fixation following minimally invasive spine repair with the company’s SpineJack device, or following conventional vertebroplasty. |
| |
|
|
|
 |
|
|
|
Orthos receives CE Mark for new synthetic bone graft substitute |
|
|
| Bone substitute materials
: 21 March, 2011 |
|
The UK orthobiologics company, Orthos Limited receives CE approval to market its proprietary βGel synthetic bone graft substitute for use as a bone filler in non-structural areas such as in spinal cages to assist fusion, inside acetabular defects caused by osteolysis and alongside pins and plates to assist bone fracture repair. |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
| First | Prev | 1 | 2 | 3 | 4 | Next | Last |